Heron Therapeutics, Inc. (HRTX) Live Share Price, Invest From India

Heron Therapeutics, Inc. Stock Performance

as on March 11, 2026 at 6:59 am IST

Day's Low
Day's High
$0.97
Day's Price Range
$1.04
$0.99
2.02%
Downside
5.05%
Upside
52 Week's Low
52 Week's High
$0.91
52-Week Price Range
$2.61
$0.99
8.17%
Downside
163.64%
Upside

Heron Therapeutics, Inc. share price movements today

Previous Close: $1.00
Open: $1.00
Volume: 2.0M
Day's Low - High: $0.97 - $1.04
52 Week Low - High: $0.91 - $2.61

Heron Therapeutics, Inc. Historical Returns

1 Month Return: -21.54 %
3 Month Return: -27.26 %
1 Year Return: -55.11 %
3 Year Return: -53.87 %
5 Year Return: -94.09 %

Heron Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Heron Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$177.2M

EPS (TTM)

-0.03

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

-0.18

EBITDA

-224.0K

Revenue (TTM)

154.9M

Profit Margin

-13.04%

Return On Equity TTM

-2408.88%

Heron Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Heron Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Heron Therapeutics, Inc.	BUY	$177.2M	-94.09%	NA	-13.04%
Alnylam Pharmaceuticals, Inc.	BUY	$42.5B	140.27%	137.03	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$116.0B	115.07%	29.85	32.94%
Beone Medicines Ltd	NA	$33.3B	NA	590.43	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$80.3B	67.03%	18.31	31.41%

Stock Returns calculator for Heron Therapeutics, Inc. Stock including INR - Dollar returns

The Heron Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Heron Therapeutics, Inc. investment value today

Current value as on today

₹49,787

Returns

₹50,213

(-50.21%)

Returns from Heron Therapeutics, Inc. Stock

₹55,405 (-55.41%)

Dollar Returns*

₹5,192 (+5.19%)

Analyst Recommendation on Heron Therapeutics, Inc. Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Heron Therapeutics, Inc.. Average target price of $4.33

Heron Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Heron Therapeutics, Inc..

What analysts predicted

77.14%UPSIDE

Target Price

$4.33

Current Price

$0.99

Analyzed by

10 Analysts

Target

$4.33

Heron Therapeutics, Inc. target price $4.33, a slight upside of 77.14% compared to current price of $0.99. According to 10 analysts rating.

Heron Therapeutics, Inc. Stock’s Investor Sentiment and Interest

Search interest for Heron Therapeutics, Inc. Stock has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.

Time period: February 9, 2026 to March 11, 2026

Change:-10% versus previous 30 day period

Heron Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	31	34	34	36	32	40	38	37	38	40
Gross Profit	13	24	26	25	23	30	30	27	22	32
Operating Income	-24	-10	-4	-6	-4	4	3	-1	-4	0
EBITDA	-24	-5	-4	-5	-3	8	3	-1	-13	0
Interest Expense	0	2	0	0	0	4	0	0	2	1
Depreciation	0	0	0	0	0	0	0	0	0	-
Income Before Tax	-25	-10	-3	-9	-4	3	2	-2	-17	-2
Income Tax Expense	0	0	0	-	-	-	-	-	-	-
Net Income	-25	-10	-3	-9	-4	3	2	-2	-17	-2
Net Profit Margin	-79.56%	-31.33%	-9.11%	-25.64%	-14.78%	8.98%	6.77%	-6.40%	-45.78%	-7.28%

Heron Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	1	30	77	145	88	86	107	127	144	154
Gross Profit	1	26	49	84	52	40	52	61	105	113
Operating Income	-170	-194	-183	-210	-228	-217	-174	-110	-11	-2
EBITDA	-169	-192	-182	-201	-225	-214	-171	-103	-5	-17
Interest Expense	2	3	2	1	1	2	2	3	6	-
Depreciation	-	1	1	2	2	3	2	2	2	-
Income Before Tax	-173	-197	-178	-204	-227	-220	-182	-110	-13	-20
Income Tax Expense	-1	3	7	1	-2	-3	-47	2	-	-
Net Income	-173	-197	-178	-204	-224	-217	-134	-110	-13	-20
Net Profit Margin	-13537.37%	-641.87%	-230.84%	-140.27%	-253.20%	-252.08%	-124.93%	-87.02%	-9.41%	-13.04%

Heron Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-10	-3	-9	-4	3	2	-2	-17	-2
Operating Cash Flow	2	-9	-4	3	-11	-8	-10	1	-9
Investing Cash Flow	-8	1	2	3	11	2	7	11	-5
Financing Cash Flow	0	0	0	0	0	0	0	13	0
Change in Cash	-6	-8	-2	7	0	-6	-2	26	-14

Heron Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-197	-178	-204	-227	-220	-182	-110	-13	-20
Operating Cash Flow	-170	-191	-124	-184	-203	-146	-58	-22	-27
Investing Cash Flow	7	-278	-21	208	32	-3	17	18	16
Financing Cash Flow	293	357	186	9	156	75	54	0	14
Change in Cash	131	-112	40	33	-14	-75	13	-2	2

Global Institutional Holdings in Heron Therapeutics, Inc.

Funds	Holdings
Citadel Advisors Llc	1.44%
Clearline Capital LP	6.49%
Adage Capital Partners Gp LLC	5.93%
AIGH Capital Management, LLC	1.96%
Vanguard Group Inc	5.21%

See all

Insights on Heron Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 37.2M → 40.58M (in $), with an average increase of 4.3% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -17.49M → -2.95M (in $), with an average increase of 492.3% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 38.8% return, outperforming this stock by 93.9%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 77.2% return, outperforming this stock by 131.1%
NEGATIVE IMPACT
Price Dip
In the last 7 days, HRTX stock has moved down by -13.3%

About Heron Therapeutics, Inc.

heron therapeutics, inc. (formerly a.p. pharma, inc.) is a specialty pharmaceutical company developing products using its proprietary biochronomer™ polymer-based drug delivery platform. this drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.

Organisation	Heron Therapeutics, Inc.
Headquarters	100 Regency Forest Drive, Cary, NC, United States, 27518
Industry	Health Technology
CEO	Mr. Craig Alexander Collard
E-voting on shares	Click here to vote

Key Management of Heron Therapeutics, Inc.

Name	Title
Mr. Mark E. Hensley	Executive VP & COO
Mr. Ryan Craig	Vice President of Marketing
Mr. John Aiken	Executive Director of People Management & Training
Dr. John C. Arthur Ph.D.	Senior Vice President of Manufacturing & Supply
Ms. Ira Duarte	Executive VP & CFO
Dr. William P. Forbes Pharm. D., Pharm.D.	Executive VP & Chief Development Officer
Mr. Robert Sullivan	Senior Vice President of Oncology Care Franchise & Commercial Operations
Mr. Brett Fleshman	Chief Business Officer
Mr. Craig Alexander Collard	CEO & Director
Melissa Jarel	Executive Director of Legal

FAQs

What is Heron Therapeutics, Inc. share price today?

Heron Therapeutics, Inc. share price today is $0.99 as on March 11, 2026 at 1:29 am IST. Heron Therapeutics, Inc. share today touched a day high of $1.04 and a low of $0.97.

What is the 52 week high and 52 week low for Heron Therapeutics, Inc. share?

Heron Therapeutics, Inc. share touched a 52 week high of $2.61 on May 6, 2025 and a 52 week low of $0.91 on March 9, 2026. Heron Therapeutics, Inc. stock price today i.e. March 11, 2026 at 1:29 am IST is trending at $0.99,which is 62.07% down from its 52 week high and 8.89% up from its 52 week low.

What is Heron Therapeutics, Inc.'s market capitalisation today?

Heron Therapeutics, Inc. market capitalisation is $0.00T as on March 11, 2026 at 1:29 am IST.

How to invest in Heron Therapeutics, Inc. Stock (HRTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Heron Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Heron Therapeutics, Inc. Shares that will get you 1.5152 shares as per Heron Therapeutics, Inc. share price of $0.99 per share as on March 11, 2026 at 1:29 am IST.

What is the minimum amount required to buy Heron Therapeutics, Inc. Stock (HRTX) from India?

Indian investors can start investing in Heron Therapeutics, Inc. (HRTX) shares with as little as ₹91.833 or $1 (as of March 11, 2026 at 1:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹918.33 in Heron Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on March 11, 2026 at 1:41 am IST). Based on Heron Therapeutics, Inc. share’s latest price of $0.99 as on March 11, 2026 at 1:29 am IST, you will get 10.1010 shares of Heron Therapeutics, Inc.. Learn more about fractional shares .

What are the returns that Heron Therapeutics, Inc. has given to Indian investors in the last 5 years?

Heron Therapeutics, Inc. stock has given -94.09% share price returns and 26.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?